Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
Clinical trial NCT02364479 · COMPLETED
Trial details
- NCT number
- NCT02364479
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-10
- Primary completion
- 2016-07-28
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.